Evidence map›Paper›PMID 28702095›Full record

ReviewPrzeglad gastroenterologiczny2017

Butyric acid - a well-known molecule revisited.

Katarzyna Borycka-Kiciak, Tomasz Banasiewicz, Grażyna Rydzewska

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Przeglad gastroenterologiczny, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06653426 (The Effect of Sodium Butyrate on Menstrual Symptoms in Women), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06653426 narecruitingnot on this mapstarted 2024, after this paper: background citation

The Effect of Sodium Butyrate on Menstrual Symptoms in Women

TypeinterventionalSponsorMagdy Milad, MDRan2024 to 2026Enrolled15ConditionsMenstrual SymptomsArmsSodium Butyrate (NaBu)
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Butyric Acid from ProbioticInternational journal of molecular sciences · 2019
    Article
  13. Review
  14. Metabolic engineering ofBiotechnology for biofuels · 2019
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Katarzyna Borycka-KiciakDepartment of General and Gastrointestinal Surgery MCPE, Orlowski Hospital, Warsaw, Poland.
Tomasz BanasiewiczDepartment of General and Endocinological Surgery, and Gastrointestinal Oncology, Poznan University of Medical Sciences, Poznan, Poland.
Grażyna RydzewskaDepartment of Internal Medicine and Gastroenterology, Division of Inflammatory Bowel Diseases, Central Clinical Hospital of Ministry of Internal Affairs and Administration, Warsaw, Poland.
Central Clinical Hospital · PLPoznan University of Medical Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The properties of butyric acid, and the role it plays in the gastrointestinal tract, have been known for many years. However, the newest research shows that butyric acid still remains a molecule with a potential that has not as yet been fully exploited. The article provides an outline of relevant up-to-date knowledge about butyric acid, and presents the expert position on the clinical benefits of using butyric acid products in the therapy of gastrointestinal diseases.

Indexed as

butyric acidconstipationdiarrheainflammatory bowel diseaseirritable bowel syndrome

Identifiers

PMID28702095
PMCPMC5497138
OpenAlexW2625718255

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.